Vitamin B2 in Athletes: What Riboflavin Actually Does to Your Blood Work and Performance
Table of Contents
Key Takeaways: Vitamin B2 in Athletes
- Vitamin B2 in athletes is biochemically important, but it is not a routine performance marker.
- Riboflavin supports energy metabolism, glutathione recycling, hemoglobin metabolism, and red blood cell function.
- Athletic status alone is not an indication to measure vitamin B2.
- In athletes with fatigue, poor recovery, or stalled performance, first-line testing should usually focus on blood count, iron status, thyroid function, energy availability, and overall clinical context.
- Riboflavin becomes more relevant in selected risk groups, such as athletes with restrictive diets, prolonged energy deficiency, poorly planned vegan diets, eating disorders, malabsorption, alcohol overuse, or unexplained low-normal hemoglobin.
- For most athletes eating a varied diet, routine vitamin B2 testing or supplementation is not necessary.
Introduction: Vitamin B2 in Athletes
Most athletes who run regular blood panels focus on ferritin, hemoglobin, and vitamin D. This is understandable, as these markers are familiar, easy to interpret, often included in standard laboratory panels, and directly connected to fatigue, recovery, and performance. Riboflavin, or vitamin B2, rarely receives the same attention. In routine clinical practice, I do not commonly see riboflavin measured, and most athletes have never had it discussed as part of their blood work.
Clinically, I probably encounter riboflavin most often in the context of cracked corners of the mouth, although in my own experience angular cheilitis is usually caused by something other than vitamin B2 deficiency. Riboflavin deficiency remains one possible differential diagnosis, but it is not usually the first explanation. Severe riboflavin deficiency is also not something I commonly encounter in practice. That creates an interesting contrast: riboflavin is biochemically central to energy metabolism, yet clinically obvious, metabolism-compromising deficiency is rarely seen in everyday medicine.
For athletes, however, the question is not only whether severe deficiency is common. Riboflavin has roles in energy metabolism, glutathione recycling, and hematologic function. Current research suggests that exercise may increase the requirements for riboflavin and vitamin B-6, while active individuals with poor or marginal nutritional status for a B-vitamin may have decreased ability to perform exercise at high intensities [1]. Excess riboflavin is not stored and is rapidly eliminated via renal excretion [9], meaning status depends on consistent dietary supply.
Deficiency may develop gradually in athletes who maintain chronically marginal intakes alongside high training demands, although the clinical trajectory of this process in athletes has not been well characterized in the literature. This article covers the biochemistry of vitamin B2 in athletes, the specific mechanisms by which training may increase demand, what the research shows about status in active populations, the link between riboflavin and hemoglobin, and how to interpret findings in a clinical context.
Why Vitamin B2 in Athletes Is More Than an Energy Vitamin
Riboflavin’s biological significance scales with how broadly it operates. The human genome contains 90 genes encoding for flavin-dependent proteins, six for riboflavin uptake and transformation into the active coenzymes FMN and FAD as well as two for the reduction to the dihydroflavin form [2]. Flavoproteins utilize either FMN (16%) or FAD (84%), and the majority of flavin-dependent enzymes catalyze oxidation–reduction processes in primary metabolic pathways such as the citric acid cycle, β-oxidation and degradation of amino acids [2]. This is not a peripheral vitamin. It is structurally embedded in almost every major energy pathway the body runs.
For athletes, two functions carry particular weight. First, vitamin B2 acts as a precursor for the electron carriers flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which are both essential mitochondrial cofactors of oxidative phosphorylation (OXPHOS) complexes I and II, respectively [4]. The higher an athlete’s aerobic demand, the more relentlessly that process operates — and the more riboflavin throughput it requires to sustain. Second, FAD is an essential cofactor for the antioxidant enzyme glutathione reductase (GR) [4]. GR regenerates reduced glutathione — the primary intracellular antioxidant. Every training session generates reactive oxygen species; adequate vitamin B2 status is part of how the body manages that oxidative load efficiently.
The parallel with vitamin B1 in athletes is worth noting: both B1 and B2 are coenzyme-dependent vitamins whose requirements may scale with training volume, yet both are routinely absent from standard athletic screening panels. Vitamin E in athletes and vitamin C in athletes are more commonly discussed for their antioxidant roles, but riboflavin-dependent glutathione reductase activity is a foundational upstream step in that same defense system.
Although vitamin B2 has a central biochemical role in metabolism, I rarely see riboflavin deficiency as the leading clinical suspicion in athletes. When an athlete presents with fatigue, stalled performance, symptoms of overreaching, or possible burnout, the first-line evaluation usually focuses on more common and clinically interpretable causes. In practice, this often means checking the blood count, iron status, thyroid function, and sometimes a broader laboratory panel depending on the case.
Even when riboflavin is included in a broader panel and appears low or borderline, it can be difficult to connect that finding directly to the athlete’s symptoms. Fatigue, poor recovery, and performance decline are usually multifactorial. Training load, sleep, energy availability, iron status, endocrine function, psychological stress, and illness history often matter more than a single isolated micronutrient result. For that reason, I do not see vitamin B2 as a routine supplement for most athletes who eat a varied diet. In most cases, adequate dietary intake is enough. Riboflavin becomes more clinically interesting when the athlete has restricted energy intake, limited food variety, unexplained low-normal hemoglobin, or poor response to otherwise appropriate iron supplementation.
Exercise May Increase Riboflavin Demand: What the Evidence Shows
The clinically important question for vitamin B2 in athletes is not just what it does in steady state, but whether training reduces status when intake is marginal. Several lines of evidence suggest this risk is real, though studies are contradictory [4].
Studies have demonstrated that longer-term exercise interventions of three weeks up to three months resulted in a lower vitamin B2 status [4]. Because exercise stresses metabolic pathways that depend on thiamine, riboflavin, and vitamin B-6, the requirements for these vitamins may be increased in athletes and active individuals [3]. Mechanistically, exercise could increase the need for these micronutrients through increased turnover, metabolism, or loss of the nutrients, through biochemical adaptation as a result of training that increases nutrient needs, or through an increase in mitochondrial enzymes that require the nutrients [3].
One controlled metabolic study offers a direct illustration. In young women undergoing caloric restriction, riboflavin depletion, as measured by increased erythrocyte glutathione reductase activity coefficients and decreased urinary excretion of riboflavin, occurred during both nonexercise and exercise periods [5]. Urinary excretion of riboflavin fell from 48 ± 12% of intake during baseline to 30 ± 13% during the nonexercise period and to 19 ± 6% during the exercise period [5]. While this study was conducted in an energy-restricted population rather than athletes per se, it illustrates the additive effect of caloric restriction and exercise on riboflavin retention — a combination common in weight-category sports.
Exercise appears to decrease nutrient status even further in active individuals with preexisting marginal vitamin intakes or marginal body stores, and active individuals who restrict their energy intake or make poor dietary choices are at greatest risk for poor thiamine, riboflavin, and vitamin B-6 status [3].
Although exercise may increase riboflavin demand, I would still usually look first at diet if an athlete actually develops low or borderline vitamin B2 status. In most cases, the problem is unlikely to be training alone. It is more likely to appear when high training load is combined with low intake, restricted food choices, or prolonged energy deficiency.
This is especially relevant in athletes with unusually restrictive diets, weight-class athletes during cutting phases, vegan athletes who do not plan their diet carefully, and athletes with disordered eating or anorexia. Similar patterns can also occur in aesthetic and skill-based sports, such as figure skating or gymnastics, where high training volumes may coexist with strict dietary control. In these situations, riboflavin deficiency is not usually an isolated problem; it is more likely to be one part of a broader picture of low energy availability and insufficient micronutrient intake.
Riboflavin Status in Active Populations: What Studies Actually Found
How prevalent is suboptimal vitamin B2 in athletes? The evidence depends heavily on dietary adequacy and sex.
A study examining 62 performance athletes across multiple sport disciplines found that when dietary intake was assessed against standard reference thresholds, all sports groups were above guideline levels of 1.5 or 1.7 mg/day, and more than 90% of the athletes were above the blood reference value of 327 nmol/liter [7]. On the functional EGRAC measure, all of the athletes were below the alpha-EGR reference value of <1.50, indicating a good overall supply [7]. Athletes consuming adequate, varied energy can maintain acceptable riboflavin status — but adequate energy intake is not universal across athletic populations.
The picture in active women is considerably less reassuring. One study comparing high-fit (VO₂peak ≥ 47 mL/kg/min, N = 15) and low-fit (VO₂peak ≤ 37 mL/kg/min, N = 16) young females found that vitamin B2 status was suboptimal (EGRAC > 1.3) in almost all females: 15 out of 16 low-fit and 13 out of 15 high-fit females [4]. In this small study, mean habitual vitamin B2 intake was close to the RDA, and many participants had EGRAC values above 1.3 [4] — though the limited sample size and observational nature of this finding warrant caution in broader generalization.
High-fitness individuals have been suggested to be at risk of a poor vitamin B2 status due to a potentially higher vitamin B2 demand [4]. Regular aerobic exercise may increase activity within metabolic pathways that depend on vitamin B2-containing cofactors, potentially raising riboflavin demand above resting-state requirements [4]. Adequate status for sedentary metabolic demands does not automatically translate to adequacy under athletic ones.
In my view, athletic status alone is not an indication to measure vitamin B2. Riboflavin is not something I would routinely add to a standard athlete blood panel unless there is a specific clinical reason to suspect deficiency or a clear risk factor in the background. Even in athletes, riboflavin deficiency is rarely the main explanation for fatigue, poor recovery, or performance decline.
The indications for considering riboflavin status are broadly similar to those in the general population. I would think about it more in athletes with a highly restrictive diet, vegan diet, eating disorder, alcohol overuse, inflammatory bowel disease, coeliac disease, or another condition that could impair absorption. Certain medications may also affect riboflavin status, although in routine clinical practice this is not something that is commonly identified as the decisive explanation.
Even in malabsorption states, riboflavin is usually not the first nutrient I worry about. Iron, B12, folate, vitamin D, calcium, protein intake, and overall energy availability are often more clinically urgent. For that reason, I would not include vitamin B2 in routine athlete screening without a specific clinical suspicion. It is better understood as a targeted consideration in selected risk groups rather than a universal performance marker.
The Riboflavin–Hemoglobin Connection in Vitamin B2 in Athletes
One of the less widely recognized implications of vitamin B2 status is its influence on hematological function. Poor riboflavin status is not only an energy metabolism concern — it is also a hemoglobin concern.
In the RIBOFEM randomized controlled trial, conducted in young women from the general population (not athletes), 123 women with biochemical evidence of riboflavin deficiency (EGRAC >1.40) were randomly assigned to receive 2 or 4 mg riboflavin or a placebo for 8 weeks [6]. For women who received supplemental riboflavin, an increase in hemoglobin status correlated with improved riboflavin status (P < 0.02) [6]. Women in the lowest tertile of riboflavin status at baseline (EGRAC >1.65) showed a significantly greater increase in hemoglobin status in response to the supplement than did women in the first and second tertiles (P < 0.01) [6]. Because iron intake and iron absorption did not change during the study [6], the hemoglobin improvement may have been related to riboflavin status rather than to altered iron availability.
The trial’s conclusion is explicit: moderately poor riboflavin status can affect iron status — the lower the riboflavin status, the greater the hematologic benefits of improving status [6]. While RIBOFEM was conducted in a general population, the underlying mechanism — riboflavin-dependent iron utilization — is a biologically plausible consideration across populations. In clinical practice, athletes presenting with persistent low-normal hemoglobin or iron deficiency that responds poorly to supplementation may warrant consideration of riboflavin status, though this represents clinical extrapolation from general-population RCT data rather than a finding from athlete-specific research.
It is also worth noting that riboflavin contributes to homocysteine metabolism through its role in two pathways: FAD is required by methylenetetrahydrofolate reductase (MTHFR) in the folate cycle, and FMN acts as a cofactor for pyridoxamine phosphate oxidase, which is needed for the generation of pyridoxal 5′-phosphate — the active form of vitamin B6 required for homocysteine transsulfuration [8]. Elevated homocysteine can therefore reflect upstream riboflavin insufficiency, a pattern worth recognizing when interpreting results together.
Although riboflavin has a real role in hemoglobin metabolism and red blood cell function, it is important to keep this in proportion. In everyday clinical practice, other B vitamins usually receive more attention in the hematologic context — especially folate and vitamin B12. That is understandable, because folate and B12 deficiencies are well-established causes of anemia and are routinely included in standard anemia evaluations.
Riboflavin is different. It is not typically part of an anemia panel, and I would not usually measure it as a first-line test when evaluating low hemoglobin or fatigue. In my practice, riboflavin becomes more relevant only after more common explanations have been considered first — such as iron deficiency, B12 or folate deficiency, inflammation, thyroid dysfunction, low energy availability, or other clinical causes. Iron deficiency typically pushes MCV downward toward microcytosis, whereas vitamin B12 or folate deficiency tends to push MCV upward toward macrocytosis. That red cell pattern is often more clinically useful at the first stage than riboflavin testing itself.
The MCV changes in athletes article covers the red cell morphology context in more detail; footstrike hemolysis and related iron losses are a separate contributor that can compound nutritional deficits. In that sense, the riboflavin–hemoglobin connection is clinically interesting, but still more of a targeted consideration than an everyday anemia workup item.
Conclusion: Vitamin B2 in Athletes
Vitamin B2 in athletes is a good example of a nutrient that is biochemically important but clinically easy to overemphasize. Riboflavin supports energy metabolism, mitochondrial function, glutathione recycling, hemoglobin metabolism, and red blood cell biology. These roles make it relevant to athletic physiology, but they do not mean that every athlete needs riboflavin testing or supplementation.
In routine practice, athletic status alone is not an indication to measure vitamin B2. When an athlete presents with fatigue, poor recovery, stalled performance, low hemoglobin, or symptoms suggestive of overreaching, the first-line evaluation should still focus on more common and clinically interpretable causes. Blood count, iron status, thyroid function, energy availability, sleep, training load, recent illness, psychological stress, and overall nutrition usually provide more useful information than an isolated riboflavin result.
Where riboflavin becomes more interesting is in selected risk groups. Athletes with restrictive diets, prolonged caloric deficit, poorly planned vegan diets, eating disorders, malabsorption, alcohol overuse, or unexplained low-normal hemoglobin may warrant closer consideration. It may also be relevant when iron supplementation does not produce the expected hematologic response, especially after more common causes have already been considered. Even then, vitamin B2 should usually be interpreted as one part of a broader nutritional and clinical picture rather than as a stand-alone explanation for poor performance.
For most athletes eating a varied diet, routine riboflavin testing is not necessary, and supplementation is unlikely to be a meaningful performance intervention. The practical message is therefore balanced: vitamin B2 should not be ignored, but it should not be turned into another routine “optimization” marker without clinical context. It deserves attention when the athlete’s history, diet, blood work, or response to treatment gives a real reason to suspect marginal status.
Bibliography
[1] https://pubmed.ncbi.nlm.nih.gov/17240780/
[2] https://pubmed.ncbi.nlm.nih.gov/23500531/
[3] https://pubmed.ncbi.nlm.nih.gov/10919966/
[4] https://pmc.ncbi.nlm.nih.gov/articles/PMC8618623/
[5] https://pubmed.ncbi.nlm.nih.gov/6475825/
[6] https://pubmed.ncbi.nlm.nih.gov/21525198/
[7] https://pubmed.ncbi.nlm.nih.gov/8089768/
